Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo US Bio-TechNSE:INDOUS -1.19%64 EV-to-EBITDA is 11.96 as of Sep. 02, 2026, which is 57% below its 10-year median of 27.83. GuruFocus rates NSE:INDOUS with a GF Score™ of 64/100 and a GF Value™ of ₹297.03 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 212 Agriculture companies, Indo US Bio-Tech ranks worse than 57.08% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Indo US Bio-Tech's enterprise value is ₹1,875 Mil.
Indo US Bio-Tech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was ₹157 Mil. Therefore, Indo US Bio-Tech's EV-to-EBITDA for today is 11.96.
The historical rank and industry rank for Indo US Bio-Tech's EV-to-EBITDA or its related term are showing as below:
NSE:INDOUS'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 10.39 Med: 27.83 Max: 56.69
Current: 11.96
During the past 13 years, the highest EV-to-EBITDA of Indo US Bio-Tech was 56.69. The lowest was 10.39. And the median was 27.83.
NSE:INDOUS's EV-to-EBITDA is ranked worse than 57.08% of 212
companies
in the Agriculture industry
Industry Median: 9.695
vs NSE:INDOUS: 11.96
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Indo US Bio-Tech (NSE:INDOUS) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Indo US Bio-Tech's PE Ratio (TTM) for today is calculated as:
Indo US Bio-Tech's share price for today is ₹78.15.
Indo US Bio-Tech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5.700.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Indo US Bio-Tech's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOUS vs CTVA, CF, MOS: EV-to-EBITDA Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech EV-to-EBITDA vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's EV-to-EBITDA falls into.
Indo US Bio-Tech's current Enterprise Value is ₹1,875 Mil.
Indo US Bio-Tech's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹157 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indo US Bio-Tech (NSE:INDOUS) has a EV-to-EBITDA of 11.96 as of Sep. 02, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Indo US Bio-Tech. This is 57% below median its historical median of 27.83. Over the past decade, Indo US Bio-Tech's EV-to-EBITDA has ranged from 10.39 to 56.69. According to the industry distribution chart, Indo US Bio-Tech ranks #121 out of 212 companies in the Agriculture industry, placing it in the top 57.1%.
Is Indo US Bio-Tech's EV-to-EBITDA too high?
Indo US Bio-Tech's current EV-to-EBITDA of 11.96 is 57% below median its 10-year median of 27.83. Over the past 10 years, this metric has ranged from a low of 10.39 to a high of 56.69. The Agriculture industry median EV-to-EBITDA is 9.70. Indo US Bio-Tech's value of 11.96 is 23.4% above this industry median. Based on the distribution chart, Indo US Bio-Tech ranks #121 out of 212 companies in the Agriculture industry, which is below the industry midpoint. Overall, Indo US Bio-Tech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's EV-to-EBITDA compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #121 out of 212 companies for EV-to-EBITDA. This places Indo US Bio-Tech in the lower half of its industry. The industry median EV-to-EBITDA is 9.70. Indo US Bio-Tech's value of 11.96 is 23.4% above this benchmark. Historically, Indo US Bio-Tech's own EV-to-EBITDA has ranged from 10.39 to 56.69 over the past decade. While the company's 10-year median is 27.83 vs. the industry median of 9.70, Indo US Bio-Tech has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Agriculture company?
The median EV-to-EBITDA among Agriculture companies is 9.70, based on 212 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo US Bio-Tech's current EV-to-EBITDA of 11.96 is 23.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Indo US Bio-Tech. For the Agriculture industry, the median EV-to-EBITDA is 9.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current EV-to-EBITDA is 11.96, which is 57% below median its own 10-year median of 27.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹297.03, compared to a current price of ₹78.15 — trading 73.7% below its estimated fair value. The current EV-to-EBITDA is 11.96, which is 57% below median its 10-year median of 27.83 and 23.4% above the Agriculture industry median of 9.70. Indo US Bio-Tech's overall GF Score™ is 64/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current EV-to-EBITDA is 11.96 as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹78.15 is trading 73.7% below its estimated GF Value™ of ₹297.03.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
EV-to-EBITDA: 11.96 (57% below median its 10-year median of 27.83)
GF Value™: ₹297.03 vs. price of ₹78.15 (73.7% below fair value)
Industry Position: 23.4% above the Agriculture median (#121 of 212)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
64GF Score
Get the complete analysis for NSE:INDOUS
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
